Skip to main content
. 2017 Jun 29;8:730. doi: 10.3389/fimmu.2017.00730

Figure 8.

Figure 8

Immunization with ΔGRA17 promotes survival and inhibits brain cyst burden after infection. (A) Survival curves following challenge of ΔGRA17-immunized mice with 20 cysts of Toxoplasma gondii type II Pru strain, compared with mock-immunized mice, 70 days after immunization. The survival of mice was monitored for 35 days. A Log-rank (Mantel–Cox) test demonstrated a significant difference between the immunized and control groups (P = 0.0001). (B) Cyst burden in the brain of mice that survived to 35 days after challenge (ΔGRA17-immunized mice vs infected, non-immunized mice). Data points indicate means ± SD.